Menu does not appear
-- SiteMap

Second Meeting of the Scientific and Ethics Committee for the Clinical Study of the F1 Offspring of A-bomb Survivors Held at RERF’s Hiroshima Laboratory
The 2nd meeting of the Scientific and Ethics Committee for the Clinical Study of the
F1 Offspring of A-bomb Survivors held at the Hiroshima Laboratory

The second meeting of the Scientific and Ethics Committee for the Clinical Study of the F1 Offspring of A-bomb Survivors was held at the Hiroshima Laboratory Auditorium, starting at 2:00 p.m., January 12, 2012.

The meeting opened with a report on the first-year progress of the Longitudinal Clinical Study of the F1 Offspring of A-bomb Survivors, followed by proposals made by committee members regarding improvement of the rate of participation in the study’s health examinations. Based on the results of additional analyses examining individual multifactorial diseases with use of data from the original study examining disease prevalence conducted during the period 2000-2006, there was reportedly no evidence proving parental radiation exposure-related increases in respective disease risks. The meeting concluded with explanations about the present health examination items and draft revisions of an informed consent form and its explanatory notes concerning storage/use of biosamples, with the relevant revisions approved after the committee’s deliberations.

The first meeting of the Scientific and Ethics Committee for the Clinical Study of the F1 Offspring of A-bomb Survivors was held on July 7, 2010, at which the research protocol “Longitudinal Clinical Study of the F1 Offspring of A-bomb Survivors” was approved as continued research based on the original F1 clinical study. Accordingly, RERF embarked on health examinations of a potential cohort of about 12,000 people on November 24, 2010.